Brazil moves to reclassify IVDs with regulatory review consultation
This article was originally published in Clinica
Executive Summary
Brazil has put out for open consultation a review of the risk classification of in vitro diagnostic (IVD) products. The proposals feature a series of 13 rules that healthcare regulatory agency Anvisa would use to determine which of four classes a product should be regulated as.